Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:58 PM
Ignite Modification Date:
2025-12-24 @ 9:58 PM
NCT ID:
NCT02347332
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically confirmed recurrent and/or metastatic squamous cell carcinoma
* Documented progressive disease after chemotherapy for locoregionally advanced or recurrent/metastatic SCCHN which included a platinum derivative
* Measurable or non measurable disease
* adequate haematological, hepatic and renal functions
* WHO performance status \< 1
Exclusion Criteria:
* Nasopharyngeal carcinoma
* History of brain or leptomeningeal involvement
* Albumin level \< 35 g/L
* Patients with weight loss ≥ 5% within the last 3 months
* Grade \> 2 peripheral neuropathy at study entry
* "Third space" fluids (pleural effusion, ascites, massive edema)
* Prior treatment with vinca-alkaloids and methotrexate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT02347332
Study Brief:
Protocol Section:
NCT02347332